Most Recent
Active Super says ASIC penalty would fall on ‘poor old members’
The trustee for Active Super has argued against a $13.5 million penalty proposed by ASIC for greenwashing, saying the tax burden would impact on its members. 
Ex-EY partner’s reputation ‘only thing of value to him’, court told
An ex-EY partner accused of pocketing $700,000 in commissions in a tax loss scheme wants to vindicate his reputation at trial but is weighing whether to keep his silence, a court has heard.
Construction PRO
Meriton to face more evidence of alleged $8M defects at Symphony apartments
The owners corporation of a Meriton apartment block in Sydney can add late evidence of alleged defects, despite a judge calling the case "an example of how proceedings in the Technology and Construction List should not be conducted”.
Maurice Blackburn’s class action risk too high to duck security, court told
Maurice Blackburn should provide $1.77 million in security in a class action over add-on insurance because the firm faces high risks in other class actions which could affect its ability to cover an adverse costs order, a court has heard.
Kearney partner labelled senior manager ‘aesthetic addition’, suit says
A former senior manager at consulting giant AT Kearney, who alleges he faced racial discrimination and was unlawfully fired, has been ordered to re-file his case.
Mesoblast class action settlement wins court OK
A court has approved a $26.5 million settlement in a shareholder class action against regenerative medicine company Mesoblast.
Maxim’s injunction bid against ‘uncontrolled’ licensee refused
A judge has rejected US publisher Maxim’s bid for an injunction against an Australian business it claims has been engaging in “uncontrolled use” of its intellectual property.
Evolution Mining hit with shareholder class action
Gold miner Evolution Mining faces a class action over alleged disclosure failures in relation to its Canadian operations.
Cipla loses bid to cut short Novo Nordisk’s weight loss drug patent
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
Judge hearing Cbus case slams ‘false economy’ of concise statements
The judge hearing ASIC’s case against super fund Cbus has criticised the practice of exchanging concise statements and responses, saying it was a “false economy” of time and cost savings.